Renowned gynecologic oncologist and researcher, Susan C. Modesitt, MD, will lead the gynecologic oncology program at Winship Cancer Institute of Emory University. Photo: University of Virginia
Susan C. Modesitt, MD, is the new division director of gynecologic oncology and professor in Emory University School of Medicine's Department of Gynecology and Obstetrics. Modesitt will lead the gynecologic oncology program at Winship Cancer Institute of Emory University. Her start date was March 1, 2022. Prior to joining Emory, she was professor and division director of gynecologic oncology at the University of Virginia.
Modesitt completed her undergraduate degree in biology at Emory University as a Woodruff Scholar. She completed medical school at the University of Virginia in Charlottesville, her obstetrics and gynecology residency at the University of North Carolina in Chapel Hill and her gynecologic oncology fellowship at The University of Texas M.D. Anderson Cancer Center.
Modesitt is a fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons and has served in multiple leadership roles and committees for the Society of Gynecologic Oncology, the American College of Obstetricians and Gynecologists, the American Board of Obstetrics and Gynecology and NRG Oncology. She serves as editor-in-chief of Gynecologic Oncology Reports and has published over 110 articles, 20 book chapters/invited articles, and has been recognized annually by Castle Connolly as a Top Doctor for Cancer since 2012 and as one of the Exceptional Women in Medicine since 2017.
Her research focuses on hereditary cancers, obesity-related cancers and clinical trials in gynecologic oncology.
Modesitt will be based primarily at Emory University Hospital Midtown and Emory University Hospital.
